Britta Eiz-Vesper is a W2 professor at MHH with a strong focus on the development and translation of cell therapies using naturally occurring and genetically modified T cells. She has established the world's first registry of healthy donors for virus-specific T cells (www.alloCELL.org), and more than 800 T cell preparations have been produced. Projects are currently underway to develop CAR- and TCR-modified cells in connection with solid tumors, viral complications, and organ rejection. 

Britta Eiz-Vesper is member of National Strategy GCT, of the jury of the nTTP-GCT program, of the board of DGI, DZIF Bridging Topic “Diagnostic”, DG-GT, Spokesperson of the “GlycoCART” consortium and expert for national and international foundations